Improving Treatment Strategies for Prescription Opioid Use Disorder- Resubmission
Improving Treatment Strategies for Prescription Opioid Use Disorder- Resubmission
批准号:
9788400
负责人:
Patricia B Wright
金额:
$18.9万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2021-08-31
关键词:
12 year oldAccountingAddressAftercareAgeAmericanAttitudeBehaviorBuprenorphineCaringCessation of lifeClinical TrialsConsentDataDevelopmentDiseaseDrug Metabolic DetoxicationEconomicsEnrollmentEpidemicEthnographyEvidence based interventionExpenditureFundingGoalsHealthIndividualInterviewKnowledgeLongitudinal StudiesModelingNational Institute of Drug AbuseOpioid AntagonistOpioid agonistOpioid userOutcomeOutpatientsParticipantPerceptionPersonsPharmaceutical PreparationsPopulationPopulation HeterogeneityPrescription drug overdoseProcessPublic HealthQualitative MethodsRaceRandomizedRandomized Controlled TrialsRecoveryRelapseRuralTimeTreatment outcomeUnited StatesWithdrawal SymptomWorkbasecohortcontextual factorscontrol trialcostdisease transmissioneffective therapyevidence baseexperiencefollow-uphelp-seeking behaviorimplementation strategyimprovedimproved outcomeinnovationmedication-assisted treatmentopioid abuseopioid epidemicopioid useopioid use disorderoverdose deathpatient orientedpreferenceprescription opioidprescription opioid abusepreventreduced substance userural areasocialsocioeconomicstreatment programtreatment strategyurban area
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
There is critical need for more effective treatment strategies to address the public health crisis that exists
due to the dramatic rise in prescription opioid (PO) use disorder and the underutilization of evidence-
based medication-assisted treatments (MAT). The rise of opioid use in the rural South, where opioid
abuse rates are highest, is alarming. Elucidation of factors that promote seeking and sustaining MAT in
this population is imperative in order to improvement treatment implementation and outcomes. The aims
of this project are to: (1) identify key decision factors for seeking MAT from the perspective of persons
with PO use disorder entering outpatient PO treatment in a rural Southern state; (2) identify key decision
factors among persons with PO use disorder enrolled in outpatient MAT for continuing/discontinuing with
opioid agonist or antagonist treatment after completing detoxification; and (3) to identify and characterize
individual- and contextual-level factors contributing to successful detoxification and treatment outcomes
among a cohort of persons seeking MAT for PO use disorder at 16-week follow-up. To accomplish this,
we will conduct a 16 week focused ethnographic study that includes in-depth qualitative interviews with
30 treatment-seeking individuals with PO use disorder who are enrolled in an ongoing clinical trial
(R01DA039088) that seeks to improve treatment, retention and outcomes for PO use disorder. Given the
current dearth of information regarding treatment-seeking for PO use disorder among rural PO users,
qualitative methods will allow us to develop an in-depth, detailed analysis of the complexities surrounding
this important decision. Findings from this study will increase our understanding of the related personal,
social, and treatment-related issues that influence treatment decisions among rural PO users. These data
will be invaluable as we move from understanding treatment-seeking to developing evidence-based
interventions that are acceptable, promoting retention, to rural persons with PO use disorder, as they will
be based on their perspectives and tailored to their needs and preferences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金